Hudson Bay Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-40,000
| Closed | -$4.08M | – | 936 |
|
|
2023
Q2 | $4.08M | Buy |
+40,000
| New | +$4.08M | 0.03% | 308 |
|
|
2023
Q1 | – | Sell |
-20,000
| Closed | -$760K | – | 1056 |
|
|
2022
Q4 | $760K | Buy |
+20,000
| New | +$760K | 0.01% | 664 |
|
|
2021
Q2 | – | Sell |
-6,205
| Closed | -$619K | – | 1081 |
|
|
2021
Q1 | $619K | Buy |
+6,205
| New | +$619K | 0.01% | 707 |
|